Clinical trial · Observational
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
Prospective, Tricentric Open Trial on the Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
NCT03624712CI-TRIAL-00084864recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Uterine Neoplasms | Uterine Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| uterine neoplasms | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- uterine neoplasms
- description
- Women with operable and inoperable uterine malignomas (cervical cancer, endometrial cancer, uterine sarcoma)
- interventionNames
- Diagnostic Test: uterine neoplasms
Primary outcomes (11)
- measure
- CTC and DTC analysis
- timeFrame
- 12 months
- description
- Counting the number of tumor cells in blood and bone marrow
- measure
- HPV
- timeFrame
- 12 months
- description
- Analysis of HPV types by DNA tests in peripheral blood, bone marrow, sentinel-lymph node, cervical-, endometrial- and myometrial-tissue, intraperitoneal wash fluid
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma) * If operable: surgical primary therapy: laparoscopic/robot-assisted or open radical gyneco-oncological surgery * Written consent * Willingness and ability to participate in all study-specific procedures * Age ≥ 18 years Exclusion Criteria: * Severe and acute general disease in the last 4 weeks * Acute or chronic psychiatric disorders * Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)
References
Publications (0)
Data not yet available
No reference posted for this study.